These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26676623)

  • 21. Effects of intravesical administration of sensory neuron-specific receptor agonist on voiding function in rats with cyclophosphamide-induced cystitis.
    Honda M; Tsounapi P; Teraoka S; Kimura Y; Hikita K; Takenaka A
    Cent European J Urol; 2019; 72(2):142-148. PubMed ID: 31482020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity.
    Tyagi P; Hsieh VC; Yoshimura N; Kaufman J; Chancellor MB
    BJU Int; 2009 Dec; 104(11):1689-92. PubMed ID: 19594739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The integrative function of vagal nerves in urinary bladder activity in rats with and without intravesical noxious stimulation.
    Juszczak K; Thor PJ
    Folia Med Cracov; 2012; 52(1-2):5-16. PubMed ID: 23697211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
    Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
    Uchida S; Kurosawa S; Fujino Oki T; Kato Y; Nanri M; Yoshida K; Yamada S
    Life Sci; 2007 Jun; 80(26):2454-60. PubMed ID: 17512953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
    BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.
    Kitta T; Chancellor MB; de Groat WC; Kuno S; Nonomura K; Yoshimura N
    J Urol; 2012 May; 187(5):1890-7. PubMed ID: 22425056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
    Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
    Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of activation of peripheral and spinal tachykinin neurokinin(3) receptors on the micturition reflex in rats.
    Kamo I; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2005 Aug; 174(2):776-81. PubMed ID: 16006975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats.
    Chuang YC; Tyagi P; Huang CC; Chancellor MB; Yoshimura N
    BJU Int; 2012 Nov; 110(10):1558-64. PubMed ID: 22452546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
    Chuang YC; Fraser MO; Yu Y; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2001 Mar; 165(3):975-9. PubMed ID: 11176525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms underlying the effects of propiverine on bladder activity in rats with pelvic venous congestion and urinary frequency.
    Nishijima S; Sugaya K; Kadekawa K; Ashitomi K; Ueda T; Yamamoto H
    Biomed Res; 2019; 40(4):145-152. PubMed ID: 31413235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anticholinergic drug propiverine inhibits the protein kinase C activity in the rat urinary bladder.
    Möritz KU; Walter R; May K; Giessmann T; Siegmund W
    Pharmazie; 2005 Jan; 60(1):49-51. PubMed ID: 15700778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary urgency outcomes after propiverine treatment for an overactive bladder: the 'Propiverine study on overactive bladder including urgency data'.
    Lee KS; Lee HW; Choo MS; Paick JS; Lee JG; Seo JT; Lee JZ; Lee YS; Yoon H; Park CH; Na YG; Jeong YB; Lee JB; Park WH
    BJU Int; 2010 Jun; 105(11):1565-70. PubMed ID: 19912183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intrathecal injection of a hyperpolarization-activated channel (Ih) inhibitor ZD7288 on bladder function in urethane-anesthetized rats.
    Masuda N; Masuda H; Matsuyoshi H; Chancellor MB; de Groat WC; Yoshimura N
    Neurourol Urodyn; 2008; 27(8):838-44. PubMed ID: 18642373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
    Aizawa N; Homma Y; Igawa Y
    Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
    Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
    Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous activation of muscarinic receptors decreases subsequent non-muscarinic bladder contractions in vivo in the female rat.
    Kullmann FA; Wells GI; McKenna DG; Thor KB
    Life Sci; 2013 Apr; 92(12):733-9. PubMed ID: 23399698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.